Clinical trial
Head to Head Study Against Sevelamer Hydrochloride
NCT00441545 · Shire, Industry · Completed
Key facts
| NCT number | NCT00441545 |
|---|---|
| Title | Head to Head Study Against Sevelamer Hydrochloride |
| Official title | A Prospective, Multicenter, Open-label, Randomized, Cross-over Study to Compare the Efficacy and Safety of Fosrenol® and Sevelamer Hydrochloride in Patients Receiving Hemodialysis for End Stage Renal Disease |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Stage 5 |
| Intervention type | Drug |
| Interventions | Fosrenol (Lanthanum Carbonate), Sevelamer hydrochloride |
| Enrollment | 182 |
| Start date | Jan 5, 2007 |
| Primary completion | Jul 31, 2008 |
| Completion | Jul 31, 2008 |
| First posted | Mar 1, 2007 |
| Last update posted | Jun 11, 2021 |
| Countries | Germany, Puerto Rico, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: